File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: First trimester termination of pregnancy

TitleFirst trimester termination of pregnancy
Authors
KeywordsFirst trimester
Termination of pregnancy
Vacuum aspiration
Misoprostol
Mifepristone
Issue Date2020
PublisherBailliere Tindall. The Journal's web site is located at http://www.elsevier.com/locate/bpobgyn
Citation
Best Practice & Research: Clinical Obstetrics & Gynaecology, 2020, v. 63, p. 13-23 How to Cite?
AbstractFirst trimester termination of pregnancy (TOP) is a safe and effective procedure. The complete abortion rates of surgical and medical abortion are approximately 97% and 95%, respectively. Vacuum aspiration (VA) either by electrical suction or manual aspiration is the method of choice for surgical TOP. Risk of significant bleeding is ≤ 5% in VA, while major complications occur in <1%. The risk of infection after VA can be reduced significantly by using prophylactic antibiotics or by the screen-and-treat strategy. Pre-operative administration of misoprostol can also reduce the risk of complications. The combination of 200 mg mifepristone followed by 800 μg misoprostol 24–48 h later is recommended for first trimester medical TOP. If mifepristone is not available, misoprostol can also be used alone, but repeated doses may be required and the complete abortion rate may be lower. Due to the reduced efficacy in more advanced gestation, repeated doses of misoprostol may be required for medical TOP over 9 weeks of gestation. The complete abortion rate with this regimen is 95% or more. Gastrointestinal upsets can occur in up to 50% of women, but major complications are rare. There was no lower limit of gestational week for TOP, although extra precaution is required for the confirmation of completion of procedures and exclusion of ectopic pregnancy.
Persistent Identifierhttp://hdl.handle.net/10722/294302
ISSN
2021 Impact Factor: 4.268
2020 SCImago Journal Rankings: 1.622
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLui, MW-
dc.contributor.authorHo, PC-
dc.date.accessioned2020-11-23T08:29:26Z-
dc.date.available2020-11-23T08:29:26Z-
dc.date.issued2020-
dc.identifier.citationBest Practice & Research: Clinical Obstetrics & Gynaecology, 2020, v. 63, p. 13-23-
dc.identifier.issn1521-6934-
dc.identifier.urihttp://hdl.handle.net/10722/294302-
dc.description.abstractFirst trimester termination of pregnancy (TOP) is a safe and effective procedure. The complete abortion rates of surgical and medical abortion are approximately 97% and 95%, respectively. Vacuum aspiration (VA) either by electrical suction or manual aspiration is the method of choice for surgical TOP. Risk of significant bleeding is ≤ 5% in VA, while major complications occur in <1%. The risk of infection after VA can be reduced significantly by using prophylactic antibiotics or by the screen-and-treat strategy. Pre-operative administration of misoprostol can also reduce the risk of complications. The combination of 200 mg mifepristone followed by 800 μg misoprostol 24–48 h later is recommended for first trimester medical TOP. If mifepristone is not available, misoprostol can also be used alone, but repeated doses may be required and the complete abortion rate may be lower. Due to the reduced efficacy in more advanced gestation, repeated doses of misoprostol may be required for medical TOP over 9 weeks of gestation. The complete abortion rate with this regimen is 95% or more. Gastrointestinal upsets can occur in up to 50% of women, but major complications are rare. There was no lower limit of gestational week for TOP, although extra precaution is required for the confirmation of completion of procedures and exclusion of ectopic pregnancy.-
dc.languageeng-
dc.publisherBailliere Tindall. The Journal's web site is located at http://www.elsevier.com/locate/bpobgyn-
dc.relation.ispartofBest Practice & Research: Clinical Obstetrics & Gynaecology-
dc.subjectFirst trimester-
dc.subjectTermination of pregnancy-
dc.subjectVacuum aspiration-
dc.subjectMisoprostol-
dc.subjectMifepristone-
dc.titleFirst trimester termination of pregnancy-
dc.typeArticle-
dc.identifier.emailLui, MW: ellenlui@hku.hk-
dc.identifier.emailHo, PC: pcho@hku.hk-
dc.identifier.authorityHo, PC=rp00325-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.bpobgyn.2019.06.004-
dc.identifier.pmid31420315-
dc.identifier.scopuseid_2-s2.0-85070511847-
dc.identifier.hkuros319305-
dc.identifier.volume63-
dc.identifier.spage13-
dc.identifier.epage23-
dc.identifier.isiWOS:000518872800003-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl1521-6934-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats